Stay updated on REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial page.

Latest updates to the REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedA banner announces changes to NIH websites and states that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.8%

- Check20 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe website revision label changes from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry, v3.7.0, appears in the study record history, replacing the prior v3.6.6. This updates the page's audit trail without altering core content or user-facing information.SummaryDifference0.1%

- Check69 days agoChange DetectedThe record history adds a new revision entry (v3.6.6) and removes the prior revision (v3.6.5). This updates the study's version trail.SummaryDifference0.1%

Stay in the know with updates to REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial page.